We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-13.54%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$1.83B
AUM Growth
-$332M
Cap. Flow
-$24.8M
Cap. Flow %
-1.35%
Top 10 Hldgs %
18.11%
Holding
3,058
New
40
Increased
272
Reduced
460
Closed
69

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$4.16M
2
EGN
Energen
EGN
+$3.33M
3
LW icon
Lamb Weston
LW
+$3.12M
4
KEYS icon
Keysight
KEYS
+$3.12M
5
JKHY icon
Jack Henry & Associates
JKHY
+$3.05M

Sector Composition

Rank Sector Weight
1 Technology 13.37%
2 Financials 12.11%
3 Industrials 9.9%
4 Healthcare 9.85%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEXT icon
2901
NextDecade
NEXT
$1.82B
$3K ﹤0.01%
638
RNAC icon
2902
Cartesian Therapeutics
RNAC
$261M
$3K ﹤0.01%
34
SMLV icon
2903
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$260M
$3K ﹤0.01%
40
SPRO icon
2904
Spero Therapeutics
SPRO
$71.2M
$3K ﹤0.01%
500
VAW icon
2905
Vanguard Materials ETF
VAW
$3.08B
$3K ﹤0.01%
33
+1
+3% +$119
VERI icon
2906
Veritone
VERI
$142M
$3K ﹤0.01%
767
VHI icon
2907
Valhi
VHI
$463M
$3K ﹤0.01%
123
VRDN icon
2908
Viridian Therapeutics
VRDN
$2.63B
$3K ﹤0.01%
74
PFIE
2909
DELISTED
Profire Energy, Inc
PFIE
$3K ﹤0.01%
2,116
MARK
2910
DELISTED
Remark Holdings, Inc.
MARK
$3K ﹤0.01%
261
MTEM
2911
DELISTED
Molecular Templates, Inc.
MTEM
$3K ﹤0.01%
48
OFED
2912
DELISTED
Oconee Federal Financial Corp.
OFED
$3K ﹤0.01%
109
NMTR
2913
DELISTED
9 Meters Biopharma
NMTR
$3K ﹤0.01%
73
AMPE
2914
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$3K ﹤0.01%
24
ALNA
2915
DELISTED
Allena Pharmaceuticals
ALNA
$3K ﹤0.01%
460
LEVL
2916
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$3K ﹤0.01%
116
GEN
2917
DELISTED
Genesis Healthcare, Inc.
GEN
$3K ﹤0.01%
2,829
NEOS
2918
DELISTED
Neos Therapeutics, Inc
NEOS
$3K ﹤0.01%
2,051
FRAN
2919
DELISTED
Francesca's Holdings Corporation
FRAN
$3K ﹤0.01%
272
MJCO
2920
DELISTED
Majesco
MJCO
$3K ﹤0.01%
457
SNNA
2921
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$3K ﹤0.01%
1,275
AREX
2922
DELISTED
Approach Resources Inc.
AREX
$3K ﹤0.01%
3,777
AKAO
2923
DELISTED
Achaogen Inc
AKAO
$3K ﹤0.01%
2,546
FSNN
2924
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$3K ﹤0.01%
1,892
NYNY
2925
DELISTED
Empire Resorts, Inc.
NYNY
$3K ﹤0.01%
270

Similar funds

Ameritas Investment Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Ameritas Investment Partners held 3,058 positions worth $1.83B, down 15% from $2.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.6%. Ameritas Investment Partners opened 40 new positions and exited 69, leaving the 3,058-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

  • Ameritas Investment Partners's largest Q4 2018 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 1,920 shares worth $2.42M.
  • Ameritas Investment Partners added most to Alerian MLP ETF in Q4 2018, an estimated $15.2M increase.
  • Ameritas Investment Partners's biggest Q4 2018 reduction was Lamb Weston, cutting an estimated $3.12M.
  • Ameritas Investment Partners fully exited Praxair Inc in Q4 2018, selling an estimated $4.16M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $1.83B portfolio in Q4 2018.
  • Ameritas Investment Partners opened 40 new positions and closed 69 in Q4 2018.
  • Ameritas Investment Partners's portfolio value fell 15% quarter-over-quarter to $1.83B.

Based on Ameritas Investment Partners's 13F filing for Q4 2018, filed 12 Feb 2019.